Colfax Stock News

Stanley Black's (SWK) Q4 earnings reflect the impacts of buyout synergies, favorable pricing, lower volumes and cost inflation. It predicts year-over-year growth in earnings per share for 2022.

Graco's (GGG) Q4 earnings reflect gains from solid segmental and regional results. Cost inflation and supply-chain woes impact margins. It projects organic sales growth for 2022.

Colfax (CFX) benefits from solid product offerings and focus on innovation, healthy demand and acquisition synergies. Cost inflation and supply-chain woes are concerning.

Colfax (CFX) benefits from solid product offerings and focus on innovation, healthy demand and acquisition synergies. Cost inflation and supply-chain woes are concerning.

I continue my barbell approach with oil and chips as my industrial plays and cloud-based software and software-enabled businesses. Check out my trades here.

Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare

Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare Con

Some of the stocks that may grab investor focus today are: Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist Diversified shares climbed 22

WILMINGTON, DE, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it plans to hold

Related Stocks: MTN , ROLL , CPNG , TWLO , CDAY , XP , WRBY , CFX , ONON , CWAN , TOST , DUOL , DASH , ABNB , STNE , FTDR ,

Cintas (CTAS) Q2 earnings likely to reflect a healthy first-aid cabinet service, demand for personal protective products, innovation capabilities, and high freight, taxes, wages and energy costs.

Colfax Corporation found using ticker (CFX) now have 15 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 66 and 43 calculating the mean target price we have 56.4. Now with the previous closing price of 45.43 this would indicate that there is a potential upside of 24.1%. The 50 day moving average now sits at 49.59 while the 200 day moving average is 46.68. The company has a market cap of $6,934m. Visit the company website at: https://www.colfaxcorp.com [stock_market_widget type="chart" symbol="CFX" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment.

Colfax (NYSE:CFX) had its target price cut by research analysts at Deutsche Bank Aktiengesellschaft from $55.00 to $54.00 in a research note issued to investors on Friday, The Fly reports. The brokerage presently has a hold rating on the industrial products companys stock. Deutsche Bank Aktiengesellschafts price objective points to a potential upside of 18.86% []